TNFRSF8 and neoplasm: Major barriers to the success of CD30-CAR T include off-target elimination of other CD30-expressing cells such as other T-cells, inefficient homing to tumor, intrinsic resistance of the tumor cells, and CD30-downregulation (153, 154).